• light
  • dark

Is Corporate Medicine Suffering A Downfall?


    Gillibrand announced in February 2019 that she and Senator Sherrod Brown (D-O.H.) were introducing legislation that would “penalize pharmaceutical companies believed to be engaging in price gouging without cause, leading to price spikes for patients who rely on medication to treat diseases ranging from cancer to addiction.”






    Although Senator Richard Burr (R-N.C.) isn’t among the top 20 senators in big pharma money, he did receive the largest sum of donations from Purdue in the 2017-2018 election cycle, a total of $6,000. Since 2007, Purdue has contributed $170,250 to his campaigns, according to Kaiser Health News.

    As a result of the lawsuits, Purdue Pharma is exploring filing for bankruptcy. Filing for Chapter 11 protection “would halt the lawsuits and allow Purdue to negotiate legal claims with plaintiffs under the supervision of a U.S. bankruptcy judge,” Reuters reported this month.

    The lawsuit is only one part of the massive opioid epidemic plaguing the country, which Brown said derives from the pharmaceutical industry’s desire to make a profit.

    “If we don’t change the regulatory process for opioids, it will happen again,” Brown said.